Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT03918694
Other study ID # STUDY00143319
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date April 24, 2019
Est. completion date January 2021

Study information

Verified date January 2020
Source University of Kansas Medical Center
Contact Neena Sharma, PT, PhD, CMPT
Phone 913 588-4566
Email nsharma@kumc.edu
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

By doing this study, researchers hope to learn effects of Vit C on lumbar spine surgery outcomes.


Description:

Lumbar spine surgeries are common procedures for management of low back pain and their prevalence is increasing. However, their outcomes are less than optimal.

An effective and inexpensive solution to minimizing surgical complications and expediting recovery following lumbar spine surgery could be supplementation using high doses of vitamin C, also known as ascorbic acid. Vit C can help reduce oxidative stress and inflammation and improve immune system and body's own chemicals to fight pain.

The researchers want to examine if Vit C is effective in decreasing pain and pain medications and improving function. Gaining a better understanding of effects of Vit C on patient recovery may lead to improved outcomes.


Recruitment information / eligibility

Status Recruiting
Enrollment 40
Est. completion date January 2021
Est. primary completion date January 2021
Accepts healthy volunteers No
Gender All
Age group 45 Years to 80 Years
Eligibility Inclusion Criteria:

- Patients scheduled to have a lumbar spine fusion

- Can read and understand the English language

- BMI 35 or less

Exclusion Criteria:

- Patients taking certain medications

- lumbar spine laminectomy or discectomy

- taking a Vit C supplement

- pregnancy

- Cauda equine syndrome or spinal tumor

- neurological, neurodegenerative or cognitive issues

- renal pathology

- sickle cell anemia

- iron metabolism disorder

Study Design


Related Conditions & MeSH terms


Intervention

Dietary Supplement:
Vitamin C
Daily use of Vit C tablets
Placebo
Daily use of placebo tablets

Locations

Country Name City State
United States University of Kansas Medical Center Kansas City Kansas

Sponsors (1)

Lead Sponsor Collaborator
University of Kansas Medical Center

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Recruitment feasibility outcome The number of participants recruited and enrolled. up to 7 weeks
Primary Adherence feasibility outcome Calculate adherence in percentage as subjects enrolled versus completed up to 7 weeks
Primary Pain intensity: numeric rating pain scale self reported 0-10 numeric rating pain scale where 0=no pain and 10=most pain imagined up to 7 weeks
Primary Pain medication consumption Use of opioids and non-opioids analgesics documented in patients' health records up to 7 weeks
Primary Function Gait distance in feet will be obtained during physical therapy visit up to 7 weeks
Primary Would healing Surgical incision observation up to 7 weeks
Secondary Beck depression inventory A standard questionnaire with 1 - 40 points, 1=no depression and 40=extreme depression up to 7 weeks
Secondary Vit C level Serum level of Vit C in umol/L up to 7 weeks
Secondary Beck anxiety inventory A standard questionnaire with 21 questions. Scores 0-21=low anxiety, scores 22-35=moderate anxiety and scores 36 and above=potentially concerning level of anxiety up to 7 weeks
Secondary 2011 Fibromyalgia (FM) survey A standard questionnaire for centralized pain. Scores 3-6 in widespread pain index and 9 or greater in symptom severity suggest widespread pain up to 7 weeks
Secondary fatigue questionnaire A standard questionnaire with 10 fatigue related questions. Each measured on 1-5 Likert scale. Higher numbers indicate greater fatigue up to 7 weeks
Secondary Pittsburg sleep scale A standard questionnaires to examine sleep problems. A total of 5 scores or greater indicate poor sleep quality up to 7 weeks
Secondary Pain catastrophizing scale A standard scale to measure catastrophizing thoughts. Higher numbers indicate greater catastrophizing thoughts up to 7 weeks
See also
  Status Clinical Trial Phase
Recruiting NCT02257554 - Comparing Patients' and Surgeons' Expectations of Lumbar Spine Surgery
Recruiting NCT06020508 - Lumoptik BRIGHTPOINT Reflectometer Device for Lumbar Epidural Placement
Recruiting NCT05680259 - Assessment of the Effects of Maela Connected Follow-up on Well-being and Pain After Lumbar Spine Surgery N/A
Not yet recruiting NCT03688438 - WoundVac in Obese Patients Undergoing Lumbar Surgery N/A
Recruiting NCT04794166 - Symptom Prevalence and Severity in Lumbar Spine Surgery With and Without Dura Rupture
Completed NCT00335517 - Safety and Efficacy of DepoDur in Lumbar Spine Surgery Patients N/A
Recruiting NCT04233736 - Erector Spinae Plane Blocks (ESP) for Postoperative Pain in Lumbo-sacral Spine Surgery N/A
Recruiting NCT06303557 - Effect of ESPB on Intraoperative Remifentanil Consumption N/A
Completed NCT01743794 - Continuous Wound Infusion in Lumbar or Thoracic Surgery Phase 2/Phase 3
Completed NCT05462210 - The Effect of Mobilization Protocol Assisted With Simulated Clinical Immersion Videos on Patients Undergoing Lumbar Spine Surgery N/A
Recruiting NCT05698914 - Telehealth Mindfulness After Spine Surgery N/A
Completed NCT04648683 - Postoperative Telehealth Mindfulness Intervention After Spine Surgery N/A
Recruiting NCT05594407 - Opioid Sparing Anesthesia in Lumbar Spine Surgery N/A